LATEST ARTICLES
India
IndusLaw
Over the past two months, significant strides have been made in reforming marketing practices within the
pharmaceutical industry, alongside efforts to establish fair pricing frameworks for both drugs and medical devices.
Khurana and Khurana
Intellectual property is crucial in the cutting-edge world, where thoughts, developments, and imaginative works hold tremendous worth.
S&A Law Offices
In the realm of branding, suggestive exert a unique power, entrancing consumers' imaginations while leaving room for interpretations.
S&A Law Offices
The idea that previously discovered chemicals and compositions may be used to discover novel functions, capacities, or medicinal applications is certainly intriguing.
Ikigai Law
The framework was reportedly circulated with companies and government departments in May 2023, but has not been released for public consultation.
Ikigai Law
Medical devices companies get more time to comply with medical devices law.
Nexdigm Private Limited
The COVID-19 pandemic put a spotlight on healthcare systems across the globe and exposed areas of improvement within the system.
Majmudar & Partners
The Drugs, Medical Devices and Cosmetics Bill, 2023 (the "Drugs Bill") seeks to replace the Drugs and Cosmetics Act, 1940 (the "Drugs Act")...
Nexdigm Private Limited
Indian State Governments offer varied incentives under their respective state industrial development corporation policies to promote the set-up of new manufacturing units in the state.
S&A Law Offices
Intellectual Property Rights (IPR) play a crucial role in fostering innovation and protecting the interests of creators and inventors.
LexOrbis
There are more than 220 viruses that are known to infect humans. Within this field of viruses, RNA viruses dominate the current list of ten global health threats.
IndusLaw
The recent developments in the healthcare and pharma industry primarily focuses on high quality pharmacy education and equitable access to healthcare coupled with classification of certain new medical devices.
Intepat IP
The Department of Biotechnology (DBT), under the Ministry of Science & Technology, recently notified that the DBT Intellectual Property Guidelines in September 2023.
De Penning & De Penning
Artificial intelligence (AI) is driving a transformative wave in the pharmaceutical and biotechnology sectors. Its integration into drug discovery, diagnostics, and clinical trials...
LexOrbis
Using a combination of known elements to create a new invention is an age-old practice to stay ahead in competition.
IndusLaw
Martin Luther King Junior famously said, "Of all the forms of inequality, injustice in health is the most shocking and inhumane." Echoing this assertion, in the recently concluded...
Saikrishna & Associates
The recent past has seen a few blogposts on how public interest is factored in (or isn't) by courts. A post looking at public interest as viewed in interim injunctions for pharma cases
Luthra and Luthra Law Offices India
Pharmaceutical disputes, being the largest and fastest-growing business sectors in the world are increasingly being settled through international arbitration, particularly in the context of ...
Nexdigm Private Limited
The Government of India (GoI) has focused on encouraging manufacturing in India and introducing innovative technologies.
IndusLaw
In August 2023, the Government of India (GoI) notified the Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP Scheme)1 with a total budgetary outlay...
Mondaq Webinars
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Comparative Guides
Upcoming Events
APR28
APR29
Conference Seattle United States
Mondaq Advice Centres
